Skip to main content

Which RA patients are at increased risk of JAKi adverse events? Does disease activity matter? in the upadacitinib ph3 t

Social Author Name
David Liew
Tweet Content
Which RA patients are at increased risk of JAKi adverse events? Does disease activity matter? in the upadacitinib ph3 trials, high disease activity pts had more: serious infections HZ MACE VTE Active RA is a massive contributor to many AEs in JAKi pts #ACR24 ABST1393 @RheumNow https://t.co/DlFf9Sfbja
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×